P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT

• P. Borchmann,
• A. Lohneis,
• P. Gödel,
• H. Balke-Want,
• C. Schmid,
• F. Ayuk,
• S. Holtkamp,
• L. Hanssens,
• G. Zadoyan,
• B. Friedrichs,
• M. Assenmacher,
• I. Bürger,
• D. Schneider,
• T. Overstijns,
• C. Scheid,
• U. Holtick,
• S. Miltenyi,
• M. Hallek

Affiliations

P. Borchmann

1 Department of Internal Medicine I, University Hospital of Cologne, Cologne

A. Lohneis

1 Department of Internal Medicine I, University Hospital of Cologne, Cologne

P. Gödel

1 Department of Internal Medicine I, University Hospital of Cologne, Cologne

H. Balke-Want

1 Department of Internal Medicine I, University Hospital of Cologne, Cologne

C. Schmid

2 II. Med. Klinik Hämatologie/Onkologie, Universitätsklinikum Augsburg, Augsburg

F. Ayuk

3 Department of Stem Cell Transplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg

S. Holtkamp

4 Miltenyi Biomedicine GmbH

L. Hanssens

4 Miltenyi Biomedicine GmbH

G. Zadoyan

4 Miltenyi Biomedicine GmbH

B. Friedrichs

4 Miltenyi Biomedicine GmbH

M. Assenmacher

5 Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany

I. Bürger

5 Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany

D. Schneider

6 Lentigen Technology Inc., Gaithersburg, United States of America

T. Overstijns

4 Miltenyi Biomedicine GmbH

C. Scheid

7 Leukapheresis and Stem Cell Transplant Unit, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany

U. Holtick

7 Leukapheresis and Stem Cell Transplant Unit, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany

S. Miltenyi

5 Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany

M. Hallek

1 Department of Internal Medicine I, University Hospital of Cologne, Cologne